Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone

Journal of Dermatological Science

Volumn 24, Issue 2, 2000, Pages 126-133

  Ma, Gang ^a   Masuzawa, Mikio ^a   Hamada, Yuhko ^a   Haraguchi, Fusako ^a   Tamauchi, Hidekazu ^a   Sakurai, Yoshinori ^b   Fujimura, Takao ^a   Katsuoka, Kensei ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Etoposide; Murine angiosarcoma ISOS 1; Prednisolone; TNP 470

Indexed keywords

ETOPOSIDE; FUMAGILLOL CHLOROACETYLCARBAMATE; PREDNISOLONE;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; CYCLOHEXANES; ENDOTHELIUM, VASCULAR; ETOPOSIDE; HEMANGIOSARCOMA; INHIBITORY CONCENTRATION 50; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PREDNISOLONE; REFERENCE VALUES; SESQUITERPENES; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033752751     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00089-X     Document Type: Article

References (26)

1. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma
2. Establishment of a new murine-phenotypic angiosarcoma cells line (ISOS-1)
3. Effects of VP-16 on cell growth and metabolism of nucleic acids in mouse leukemia L-1210 cells and on the activity of DNA polymerase I of E. coli
4. Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy
5. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide
6. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
7. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
8. Treatment of murine hemangioendotheliomas with the angiogenesis inhibitor AGM-1470
9. The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice
10. A novel animal model for hemangiomas: Inhibition of hemangioma development by the angiogenesis inhibitor TNP-470
11. Fumagillin analog in the treatment of Kaposi's sarcoma: A phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team
12. Intralesional corticosteroid injection with short-term oral prednisolone for infantile hemangiomas of the eyelid and orbit
13. Role of steroid in childhood haemangioma: A 10 years review
14. Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate
15. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: A regional antiangiogenic therapy
16. Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay
17. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo
18. A method for obtaining and culturing large numbers of purified organ-derived murine endothelial cells
19. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay
20. Activity of a new glycocidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors
21. Chemotherapy for the treatment of angiosarcoma
22. AGM-1470 inhibits the growth of human glioblastoma cells in vitro and in vivo
23. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470)
24. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(Chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice
25. The combination of melphalan with prednisolone
26. A phase I study of TNP-470 administered to patients with andvanced squamous cell cancer of the cervix